德國44NA實驗分子診斷之市場分析

Abstract

This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:

• Step 1: Identification of the total number of laboratories by secondary research and short telephone interviews with 1,312 hospitals to verify existence of internal laboratories.
• Step 2: 1,251 laboratories in Germany were classified for NAT activity and overall NA test volume.
• Step 3: 107 laboratories provided data on NA test volume, kits, platforms and trends. A list of 44 NA tests have been provided to the labs for structured data entry. The report discusses tests and technologies that are currently available and wishes from the end user perspectives. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.

Table of Contents

• Total number of clinical diagnostic labs by segment
• Number of clinical diagnostic NA labs by segment
• # of lab performing test by test type
• Total # of test/results per test type & growth rate
• Market share: # of tests/results by supplier
• Installed base of analyzers
• Trends